Search

everythinglearnresearchcommunity

for

Search:↓

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Treatment improved PCOS symptoms and reduced BMI and certain immune factors.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.

Ovarian hyperthecosis can cause high testosterone and symptoms like hair loss, and surgery can help improve these symptoms.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

The ovary mainly causes high testosterone in PCO, while the adrenal gland is the main source in IH.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Lifestyle changes improve symptoms and fertility in hyper-androgenic women.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Using a protocol with LH improves pregnancy rates in patients with low ovarian reserve.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

A woman with non-classic CAH had unusual heavy periods and high hormone levels, improved with treatment.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

Follicular targeting could improve hirsutism treatment by focusing directly on hair follicles.

Taking Vitamin D with clomiphene citrate significantly improves ovulation in women with Poly Cystic Ovary Syndrome.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Hirsutism in young women is often caused by PCOS and managed with lifestyle changes, treatments, and hormonal therapy, which takes 9-12 months to work.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Obesity greatly affects polycystic ovarian syndrome, and losing weight should be the first treatment for obese patients to improve their chances of ovulation and pregnancy.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.